Sign inJoin waitlistJoin the waitlist

CB

Chiara Battelli

President · New England Cancer Specialists

Credentials: · · · · · · · ·

History

Maine Center for Cancer Medicine and Blood Disorders Pa · Mercy Hospital
Present

Hem/Onc
MaineHealth Maine Medical Center
2013–2014
Hematology and Medical Oncology
Beth Israel Deaconess Medical Center
2010–2013
Internal Medicine
MaineHealth
2007–2010
Doctor of Medicine
1994–1998

Research

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel
Cancer · 2015 · 363 citations
The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1
Molecular and cellular neurosciences · 2006 · First of 4 authors · 152 citations
mTOR inhibitors in renal cell carcinoma
Therapy · 2011 · First of 2 authors · 99 citations

Erica Mayer
2 papers
Leticia Varella
2 papers
Meredith Faggen
2 papers
Nadine Tung
2 papers
Natalie Sinclair
2 papers
Panagiotis Konstantinopoulos
2 papers
Pedro Sanz-Altamira
2 papers
Philip Poorvu
2 papers
Sara Tolaney
2 papers
SS
Sarah Sammons
2 papers
SS
Sarah Sinclair
2 papers
Shana Berwick
2 papers

Clinical trials

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Site PI · Recruiting
Natera, Inc.
2026–2037
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Site PI · Recruiting · Phase 3
NRG Oncology
2023–2034
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2023–2033
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Site PI · Recruiting · Phase 2
Dana-Farber Cancer Institute
2021–2029